BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$607M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$226M |
| 3 |
SPDR S&P Retail ETF
XRT
|
+$220M |
| 4 |
Health Care Select Sector SPDR Fund
XLV
|
+$179M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$131M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Tesla
TSLA
|
+$652M |
| 3 |
Microsoft
MSFT
|
+$601M |
| 4 |
Apple
AAPL
|
+$520M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$362M |
Sector Composition
| 1 | Technology | 17.04% |
| 2 | Financials | 11.4% |
| 3 | Healthcare | 8.84% |
| 4 | Consumer Discretionary | 8.27% |
| 5 | Industrials | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Haemonetics
HAE
$2.51B
| $680K | ﹤0.01% |
9,634
+2,738
| +40% | +$193K |
|
1927
LivaNova
LIVN
$3.07B
| $680K | ﹤0.01% |
8,586
+1,694
| +25% | +$134K |
|
1928
Mersana Therapeutics
MRSN
$35.6M
| $677K | ﹤0.01% |
2,871
+2,771
| +2,771% | +$653K |
|
1929
PC Connection
CNXN
$1.6B
| $676K | ﹤0.01% |
15,344
+5,487
| +56% | +$242K |
|
1930
Collegium Pharmaceutical
COLL
$1.18B
| $673K | ﹤0.01% |
34,081
+21,802
| +178% | +$430K |
|
1931
Hawkins
HWKN
$3.62B
| $672K | ﹤0.01% |
19,267
+12,461
| +183% | +$435K |
|
1932
DMC Global
BOOM
$145M
| $671K | ﹤0.01% |
18,168
+11,449
| +170% | +$423K |
|
1933
National Fuel Gas
NFG
$7.97B
| $670K | ﹤0.01% |
12,765
-4,905
| -28% | -$258K |
|
1934
Liberty Global Class A
LBTYA
$4.05B
| $670K | ﹤0.01% |
22,484
-18,322
| -45% | -$546K |
|
|
ALLK
1935
DELISTED
Allakos
ALLK
| $666K | ﹤0.01% |
6,294
+4,991
| +383% | +$528K |
|
1936
Clearway Energy Class C
CWEN
$3.39B
| $664K | ﹤0.01% |
21,935
+14,205
| +184% | +$430K |
|
1937
Nelnet
NNI
$4.46B
| $662K | ﹤0.01% |
8,358
+327
| +4% | +$25.9K |
|
1938
National Presto Industries
NPK
$802M
| $661K | ﹤0.01% |
8,058
+987
| +14% | +$81K |
|
1939
Hanmi Financial
HAFC
$748M
| $661K | ﹤0.01% |
32,968
+19,142
| +138% | +$384K |
|
|
EGRX
1940
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $658K | ﹤0.01% |
11,793
+7,442
| +171% | +$415K |
|
|
RUTH
1941
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $656K | ﹤0.01% |
31,660
+20,239
| +177% | +$419K |
|
1942
Insperity
NSP
$1.99B
| $653K | ﹤0.01% |
5,900
+224
| +4% | +$24.8K |
|
1943
Grifois
GRFS
$6.72B
| $653K | ﹤0.01% |
44,707
+6,271
| +16% | +$91.6K |
|
1944
ICU Medical
ICUI
$3.22B
| $648K | ﹤0.01% |
2,778
-6,986
| -72% | -$1.63M |
|
1945
WisdomTree
WT
$2.11B
| $648K | ﹤0.01% |
114,251
+74,142
| +185% | +$420K |
|
1946
Anika Therapeutics
ANIK
$125M
| $646K | ﹤0.01% |
15,173
+8,616
| +131% | +$367K |
|
|
CIR
1947
DELISTED
CIRCOR International, Inc
CIR
| $644K | ﹤0.01% |
19,502
+12,495
| +178% | +$412K |
|
1948
Alector
ALEC
$278M
| $643K | ﹤0.01% |
28,162
+8,375
| +42% | +$191K |
|
|
CHUY
1949
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $642K | ﹤0.01% |
20,371
+13,422
| +193% | +$423K |
|
1950
First Merchants
FRME
$2.31B
| $641K | ﹤0.01% |
15,314
+7,866
| +106% | +$329K |
|